(1−5) Despite these strides, the efficacy of existing immunotherapies is hampered by the immunosuppressive microenvironment of “cold” triple-negative breast cancer (TNBC), marked by inadequate T-cell ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

OpenMLDB is an open-source machine learning database that provides a feature platform computing consistent features for training and inference.

To alleviate the first limitation, we propose a novel deep learning model, the gating memory network multilayer perceptron (GMMLP). In the model, the traditional time-consuming graph-based operations ...

“Vitamin B” refers to eight different vitamins, which all play a role in converting food into energy in the body. Each vitamin has a unique role in a person’s health. Vitamin B-complex ...

There are two forms: Partial remission. Your B-cell lymphoma has gotten smaller, but it's still there. Usually the cancer has shrunk by half or more. Complete remission. Your doctor can't find any ...

Described today in the journal Science Translational Medicine, the finding gives oncologists a new target for developing immunotherapies: double negative memory B cells, so-called because they are ...

Dysfunctional CD11c − CD21 − extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer. Science Translational Medicine , 2025; 17 (786) DOI: 10.1126 ...

--(BUSINESS WIRE)--EnCharge AI, a startup developing first-of-its-kind analog in-memory-computing AI chips, today announced it has secured over $100 million in Series B funding. This latest ...